4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-19-006009
Chief Medical Officer sold 21,669 shares at $15.00 ($325,035)
- Chief Medical Officer acquired 21,669 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-09 | Option exercise | +4,614 | $9.49 | $43,787 | 12,918 | D |
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-09 | Sale | −4,614 | $15.00 | $69,210 | 8,304 | D |
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-10 | Option exercise | +17,055 | $9.49 | $161,852 | 25,359 | D |
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-10 | Sale | −17,055 | $15.00 | $255,825 | 8,304 | D |
| Derivatives | |||||||
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-09 | Option exercise · Stock Option (Right to Buy) | −4,614 | 254,099 | D | ||
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-10 | Option exercise · Stock Option (Right to Buy) | −17,055 | 237,044 | D | ||
| Open-market sales · 21,669 sh · avg $15.00 · $325,035 | |||||||
Loading xslF345X03/primarydocument.xml…